Where does Arrowhead Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Arrowhead Pharmaceuticals, Inc. ranks #3,875 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Arrowhead Pharmaceuticals, Inc. hold?

Arrowhead Pharmaceuticals, Inc. holds 93 US utility patents granted between 2016 and 2025, spanning 18 technology areas.

What is Arrowhead Pharmaceuticals, Inc.'s Innovation Score?

Arrowhead Pharmaceuticals, Inc. has an Innovation Score of 48.8 out of 100 (top 16% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Arrowhead Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Arrowhead Pharmaceuticals, Inc.'s recent grant velocity is -9% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Arrowhead Pharmaceuticals, Inc.'s patents?

Arrowhead Pharmaceuticals, Inc.'s patents average 21.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Arrowhead Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Arrowhead Pharmaceuticals, Inc.

Q: What technology areas does Arrowhead Pharmaceuticals, Inc. focus on?

Arrowhead Pharmaceuticals, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 84 patents, ranking #112 of 4,144 assignees active in that subclass. Grants appear in 18 CPC subclasses total.

USPTO PatentsView assignee record - 93 granted patents across 18 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Arrowhead ranks #3,875 of 49,997 tracked US assignees by granted-patent volume, with 93 patents across 18 technology areas.

#3,875
of 49,997 US assignees by volume: Top 16%
by Innovation Score (48.8/100): 21.7
avg claims per patent: -9%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3875 · US Corporation #3,875 · 93 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 93 grants
TOP-DECILE #3,875/49,997
PHOTO-FINISH Avon Products
CPC-FOCUS C12N · 18 areas
INNOV-PAR 48.8/100
CLAIMS-DENSE 21.7 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT -9% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Avon Products, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Arrowhead’s 48.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.7 pts (32%) Velocity 5.1 pts (10%) Breadth 15.0 pts (31%) Claim depth 13.0 pts (27%)

Qualcomm Incorporated · highest

85
APR Beauty Group · near

49
Arrowhead Pharmaceut… · this assignee

49
Haldex Brake… · near

49
Medela Holding · near

49
Quarkstar · near

49
3D Lighting… · lowest

7

What this shows Arrowhead's Innovation Score is 48.8/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Arrowhead?

Each dot is one of Arrowhead’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Arrowhead’s own 21.7 claims/patent is ABOVE the 12.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Arrowhead vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Arrowhead's grants concentrate

Arrowhead Pharmaceuticals, Inc. is a focused PatentsView assignee: 18 CPC subclasses with 90.3% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2018 (15 grants) versus a trough of 6 in 2023. By volume, Arrowhead sits between Valeo Systemes DE Controle Moteur and Chang Gung University.

Arrowhead's three-year grant acceleration

From 2019–2021 to 2022–2024, Arrowhead Pharmaceuticals, Inc. moved from 29 to 22 grants (0.76x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Valeo Systemes DE…

94
Wabco Europe Bvba

94
Wisk Aero

94
Xieon Networks r l

94
Avon Products

93
Blackpin

93
Bundesdruckerei

93
Chang Gung Univer…

93
Arrowhead Pharmac… ◀

93

What this shows Arrowhead holds 93 patents at rank #3,875, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Arrowhead

By rank, the assignees closest to #3,875 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Arrowhead's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Arrowhead, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Arrowhead ranks #112 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (49 here).

Quarkstar LLC 49 Medela Holding AG 49 APR Beauty Group Inc. 49 Haldex Brake Products Aktiebolag 49

Similar claim depth

Nearest assignees by average claims per patent (21.7 here).

Evernote Corporation 21.7 avg Phison Electronics Corp. 21.7 avg RPX Clearinghouse LLC 21.7 avg Prc-desoto International, Inc. 21.7 avg

Arrowhead's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Arrowhead Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	11	11.8%
2017	11	11.8%
2018	15	16.1%
2019	9	9.7%
2020	11	11.8%
2021	9	9.7%
2022	7	7.5%
2023	6	6.5%
2024	9	9.7%
2025partial year	5	5.4%

Which technologies does Arrowhead Pharmaceuticals, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 84

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 78

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 74

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 18

C12Y - Enzymes 12

Y02A - Technologies FOR Adaptation TO Climate Change 11

C07K - Peptides 6

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 5

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C07D - Heterocyclic Compounds 3

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

C07C - Acyclic OR Carbocyclic Compounds 1

B27B - Saws FOR Wood OR Similar MATERIAL; Components OR Accessories Therefor 1

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Arrowhead Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Arrowhead Pharmaceuticals, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 90.3% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #3,875 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Arrowhead Pharmaceuticals, Inc. against Valeo Systemes DE Controle Moteur, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.